Other potential candidate molecules that may involve in the BMEC transcytosis can be secretory aspartyl proteinases SAP1-SAP9 of C. albicans (Ibrahim et al., 1998; Naglik et al., 1999). Cryptococcus neoformans can traverse BMECs without any obvious change in their integrity.

Transmission and scanning electron microscopy has revealed that C. neoformans induces the formation of microvilli-like protrusions to initiate entry into BMECs. These findings indicate that C. neoformans uses a transcellular mechanism (Chang et al., 2004). Very recent finding (Huang et al., 2011) unfolds cryptococcal invasion via lipid raft – endocytic pathway. CD44 molecules from lipid rafts see more can directly interact with hyaluronic acid of C. neoformans. The lipid raft molecule, ganglioside GM1, colocalizes with CD44 on the plasma membrane to which C. neoformans can adhere. Upon adhesion, cryptococci are internalized into the BMECs along with GM1 through vesicular structures. Apart from CD44, this endocytosis process is dependent on microtubule cytoskeleton and intracellular kinase-DYRK3 (dual-specificity tyrosine-phosphorylation-regulated kinase 3). Histoplasma capsulatum is able to invade CNS via surface protein Yps3p. This

protein is expressed as secretory protein in infected cells and may have a regulatory role in fungal transition and pathogenicity. Yps3p triggers TLR2 signaling BGB324 manufacturer and leads to the activation of NF-κB in microglial cells (Bohse & Woods, 2005) (Table 1). Plasmodium falciparum erythrocyte membrane protein (PfEMP-1)

mediates endothelial binding and affects barrier integrity. PfEMP-1 binds to ICAM-1, CD36, chondroitin sulfate, and other trypsin-sensitive binding determinants (Tripathi et al., 2007). Pathogen matures in parasitized red blood cells, which get attached to BMECs. This process is mediated by specific molecular adhesive events. This binding is not solely static but MYO10 can be a rolling interaction, similar to the early rolling that allows subsequent leukocyte tethering to ECs during physiological responses to inflammatory stimuli (Cooke et al., 1994). The ability of trypanosomes to invade the brain and induce an inflammatory reaction is well recognized. Process of trypanosomal traversal across the human BBB requires the participation of a PAR-2-mediated calcium signaling pathway. Work of Grab and his colleagues (Grab et al., 2004) shows that Trypanosoma translocates BBB by generating Ca2+ activation signals by parasite cysteine proteases. Trypanosomal cathepsin (brucipain) can initiate BBB translocation and increases vascular permeability by interaction with host G protein-coupled receptors (Abdulla et al., 2008). The mechanism by which Acanthamoeba transmigrates the BBB is the most complex and may involve both pathogen (adhesins, proteases and phospholipases) and host factors (IL-β, IL-α, TNF-α, IFN-γ, and host cell apoptosis).

Second, PGE2 could not directly inhibit DC maturation by itself. We found that IC not only induced considerable amount of PGE2 release from FcγRIIb−/− DCs, but also promoted the maturation of FcγRIIb−/− DCs, indicating

that PGE2 alone could not inhibit DC maturation. In addition, PGE2 inhibitor, celecoxib, could not completely restore the downregulated expression Pembrolizumab of costimulatory molecules such as CD40, CD80 and CD86 and MHC class II (I-Ab) on IC-pretreated TLR-triggered DCs (data not shown). Several other investigations have presented inconsistent observations about the effect of PGE2 on the maturation of DCs. Some studies have provided evidence that PGE2 enhances the maturation of DCs by inducing costimulatory molecules and IL-12 33, 34; however, other studies have provided evidence that PGE2 from saliva of blood-sucking arthropods is a strong inhibitor of DCs maturation

35. Third, the DC-initiated T-cell proliferation that we observed above was the net consequence of the interplay between FcγRIIb−/− DC-mediated activating signals and PGE-mediated direct inhibitory signals. In the case of IC pretreatment Palbociclib of FcγRIIb−/− DCs, FcγRIIb−/− DCs were more mature because activating signals were dominant, whereas PGE2 production was reduced because of deficiency of one type of FcγR(IIb). Therefore, IC pretreatment could not significantly inhibit LPS-stimulated FcγRIIb−/− DCs to induce T-cell responses. Artificial overexpression of FcγRIIb

not only enhances PGE2 production but also may polarize IC-triggered activating signal to inhibitory signal in DCs with increased tolerogenecity. To investigate the mechanisms underlying the regulatory effect of IC pretreatment, we had also detected whether other inhibitory cytokines, such as IL-10 and TGF-β, could be produced from DC-FcγRIIb after ligation by IC. However, no increase in IL-10 PAK5 and TGF-β can be detected, suggesting that IL-10 and TGF-β were not involved in attenuating progression of lupus by DC-FcγRIIb. Although tolerogenic DCs and PGE2 have been reported to promote Treg development 30, we found that the frequency and regulatory function of Foxp3+ Tregs remained almost unchanged in MRL/lpr lupus mice after infusion of DC-FcγRIIb (data not shown), thus excluding the possibility that the regulatory role of DC-FcγRIIb was due to the induction of Foxp3+ Treg generation. In summary, our findings demonstrate that genetic modification of FcγRIIb can maintain the immature status and enhance tolerogenecity of DCs in the presence of IC. Infusion of DC-FcγRIIb can significantly attenuate T-cell response in MRL/lpr mice, leading to dampened progression of lupus.

, 2007). This alteration of the outer membrane composition is probably linked to our TEM observations, revealing that OMVs-like structures are strongly overproduced in the MG210 clumping

strain. Several roles for OMVs have been reported including involvement in DNA and QS-pheromone transport in P. aeruginosa (Renelli et al., 2004; Mashburn & Whiteley, 2005). Whether Brucella OMVs could play such a role and be directly involved in the matrix production remains to be explored. Together with exopolysaccharide and eDNA, these OMVs are the third structural element, classically described in extracellular biofilm matrices, that we have identified in B. melitensis clumps. In addition to promoting adhesion of bacteria to neighboring cells, the sticky matrix components also contribute to surface adhesiveness. Therefore, it is not surprising that the clumping strain MG210 presents better adhesion KU-60019 ic50 properties than the wild-type strain both on polystyrene and on HeLa cells (Figs 8 and 10). The exact nature of the initial adhesin and

the stepwise process leading to cell aggregation remain to be determined. As we discussed in our previous publication (Uzureau et al., 2007), the ability of B. melitensis to form biofilm-like structures could have several advantages in its life cycle. If we consider that B. melitensis is a facultative intracellular pathogen able to survive for

months outside the host on inert surfaces (Spink, 1956), we could easily imagine a protective role for the exopolysaccharide against desiccation and other environmental stresses encountered, as SCH 900776 in vivo described in Nostoc commune (Tamaru et al., 2005) or Campylobacter jejuni (Joshua et al., 2006). Nevertheless, as the genome and the molecular Fossariinae infectious strategies of Brucella spp. are very close to those of S. meliloti and considering the role of the exopolysaccharide in S. meliloti, we hypothesize a role for Brucella clumping and/or exopolysaccharide production during its infectious cycle in the host. When aggregated Brucella spp. enter in contact with their host, exopolysaccharide could offer them protection against the extracellular immune system (as described for Streptococci (Marques et al., 1992) and help them to adhere to host cells (such as Neisseria gonorrhoeae; Greiner et al., 2005). In this regard, the adhesion we observed on HeLa cells with the MG210 strain is somehow reminiscent of the localized bacterial microcolonies of B. abortus adherent to epithelial cells depicted recently (Castaňeda-Roldán et al., 2004). The exopolysaccharide could also be involved in the earliest steps of the host trafficking as described for succinoglycan in S. meliloti (reviewed in Fraysse et al., 2003). Finally, considering the variety of eukaryotic proteins dedicated to ‘mannose’ recognition (Ip et al.

Univariate analysis, which consisted of chi-squared or Fisher’s exact test for categorical independent variables and

logistic regression for continuous independent variables, was used to identify factors present at the time of initial clinical Buparlisib manufacturer presentation associated with 28-day crude mortality. A multivariable Cox Proportional Hazards Regression model was built in a forward stepwise fashion using biologically plausible variables identified by univariate analysis (P < 0.1) accounting for potential confounders. Continuous variables were analysed continuously or categorically using cut-off threshold values identified by classification and regression tree (CART) partitioning. Variables retained in the multivariate model were then assigned a weighted score based on the adjusted hazard ratios rounded to the nearest whole number from the regression model, which was then added to the baseline APACHE II score calculated at the time of PM diagnosis. Receiver–operator curves (ROC) were used to analyse the ability of the risk score PF-01367338 manufacturer to differentiate non-survivors from surviving patients

at 28 days, and assign a breakpoint score associated with high risk of early death. Antifungal and other treatment variables occurring after diagnosis were not included in the development of the model. Time to death following the initial clinical signs of PM were then compared in patients with low- vs. high-risk scores using Kaplan–Meier curves, and mortality rates were compared among groups using the log-rank test. All analysis was performed with spss version 20 (IBM, Armonck, NY) and Medcalc Software Packages (Ostend, Belgium). We identified 75 patients with PM over the 12-year study period (13 proven/62 probable) (Table 1). The male : female ratio was 2 : 1 (50 males and 25 female patients). The median Diflunisal age at diagnosis was 57 years (range, 16–76 years). The vast majority of the

patients were Caucasians (81%). Thirty patients (40%) had a diagnosis of AML or myelodysplastic syndrome. Forty-three patients (57%) had active haematological malignancy at the time of diagnosis. Moreover, 36 patients (48%) were HSCT recipients. Of these, 29 (81%) received allogeneic stem cell transplants and 19 (66%) patients had developed severe GvHD. A history of diabetes mellitus and a serum glucose level higher than 200 mg dl−1 were present in 23 (31%) and 25 (34%) patients at the time of diagnosis respectively. Neutropenia and lymphopenia were present at diagnosis in 43 (57%) and 48 (64%) patients, respectively, whereas monocytopenia was present in 39 (52%) of the study cohort. Among patients with neutropenia, 28 (65%) had an ANC count less than 100 mm−3. The median duration of neutropenia before diagnosis was 10 days (range, 1–100 days). Only 18 patients (24%) recovered from neutropenia during the infection course. In addition, among patients with lymphopenia, 34 (71%) had severe lymphopenia.

Neuropathological studies are PI3K inhibitor few in number and only limited morphological abnormalities have been described. In the genetic literature,

dystonia loci are represented as DYT and are assigned ascending numerals chronologically as they are identified. This review will concentrate on the neuropathology of primary pure dystonia, focusing on DYT1 and DYT6 and the correlation between clinical and genetic findings. Research in this area is incomplete and confounded by the rarity of post mortem brain tissue. However, recent findings, indicating a direct interaction between the torsinA (TOR1A) gene responsible for DYT1 and the thanatos-associated domain-containing apoptosis-associated protein 1 (THAP1) gene responsible for DYT6, have important implications in understanding these two entities and also for other members of this group Venetoclax of disorders. “
“Rosette-forming glioneuronal tumor (RGNT) of the fourth ventricle is a recently described novel type of primary brain tumor that was included into the current WHO classification of CNS tumors. It is a very rare, slowly growing, mixed neoplasm at cerebellar localization with distinctive morphological pattern. We present an unusual case of a 20-year-old patient

with RNGT of the fourth ventricle with advanced microvascular proliferation. MRI revealed the solid-cystic tumor mass largely involving the cerebellar vermis and left hemisphere with compression of the fourth ventricle. Microscopically, the tumor showed classical architectural pattern with two distinctive components. The main component consisted of neurocytic rosettes formed by round, isomorphic nuclei arranged around eosinophilic, fibrillar cores with strong synaptophysin expression. The perivascular rosettes with cell arrangement along blood vessels were observed only sporadically. The second neoplastic component consisted of spindle or stellate astroglial cells with piloid process and Rosenthal fibers, strongly resembling pilocytic astrocytoma. Focally, the astroglial cells showed increased cellularity but without marked

nuclear atypia. The glial part of the tumor revealed advanced proliferation of microvessels. The vessels of glomeruloid Astemizole type exhibited multilayered endothelial proliferation and marked mitotic activity. MIB1 labelling index was generally low; however, in areas exhibiting microvascular proliferation its expression was significantly increased up to 20%. This report demonstrates the unique case of RGNT with conspicuous microvascular proliferation of glomeruloid type and extensive endothelial proliferation. As there is still limited clinical experience with RGNT, further studies are necessary to evaluate the biology of this type of tumor. “
“We describe an atypical neuropatholgical phenotype of sporadic Creutzfeldt-Jakob disease (sCJD) in a 64-year-old man presenting with a 5-month history of rapidly progressive dementia, comprising behavioral disturbances, memory complaints, disorientation and language alterations.

However, OVA-pulsed viable DC that had taken up apopotic DC failed to induce OVA-specific T-cell proliferation check details (Fig. 5F). These results indicate that upon uptake of apoptotic DC but not necrotic DC, viable DC are refractory to LPS-induced maturation. As viable DC acquired a tolerogenic phenotype upon apoptotic DC uptake, we then assessed the ability of viable DC to induce Treg differentiation upon apoptotic DC uptake. Culture of naïve CD4+CD25– OT-II T cells with OVA-pulsed viable DC resulted in approximately 4–5% of naïve T

cells differentiating into Foxp3+ Treg, which increased to approximately 23–24% upon culture with OVA-pulsed Adriamycin chemical structure viable DC that had taken up apoptotic DC. In contrast, culture of naïve CD4+CD25– T cells with OVA-pulsed viable DC that had taken up necrotic DC only resulted in approximately 5–6% Foxp3+ Treg (Fig. 6A and B). The increase in the proportion of Foxp3+ Treg was not paralleled by an increase in the absolute T-cell count, indicating that it was likely the induced expression of Foxp3 and not expansion, which mediated the observed increase in the proportion of Foxp3+ Treg among T cells cultured with OVA-pulsed viable DC that had taken up apoptotic DC (data not shown). In order to test whether the induction of Foxp3+ Treg

was induced specifically upon uptake of apoptotic DC by viable immature DC and not by uptake of other types of apoptotic cells, we looked at the effects of apoptotic splenocyte uptake on the ability of viable

DC to induce Foxp3+ Treg. Results indicate that the uptake of apoptotic splenocytes did not enhance the ability of viable DC to induce Treg, as only 7–8% of naïve T cells differentiated into Foxp3+ Treg, which was similar to the control group. Furthermore, we also assessed the ability of in vitro-generated Foxp3+ Treg to suppress T-cell proliferation. oxyclozanide Our findings identify that the CD4+CD25+ T-cell subset only from the co-culture of naïve T cells and OVA-pulsed viable DC that had taken up apoptotic DC, was in fact enriched for suppressor T cells, as they were able to inhibit T-cell proliferation in a dose-dependent manner (Fig. 6C). Overall, these results indicate that it was specifically the uptake of apoptotic DC which was primarily responsible for the induction of Foxp3+ Treg by viable DC. Next, we wanted to assess whether the ability to induce Foxp3+ Treg by viable DC upon apoptotic DC uptake dependent on interaction with naïve T cells or soluble factors. This was tested by separating T cells from DC using a transwell plate followed by an assessment of Foxp3+ Treg induction.

, 2007). The biofilm serves as a skeleton for large numbers of bacteria within a single structure and confers the population of interacting organisms with protection, one of the hallmarks of multicellular organisms. Extending the skeletal

metaphor, the biofilm matrix also plays important roles in signaling control and nutrient availability. Rheological studies by Stoodley and colleagues have demonstrated that the hydrated EPS matrix is highly viscoelastic and can be rapidly remodeled BVD-523 in response to changes in shear and other environmental stressors (Dunsmore et al., 2002; Klapper et al., 2002; Stoodley et al., 2002; Towler et al., 2003; Shaw et al., 2004). Thus, in this regard, it displays qualities similar to endochondral bone in that the strength of the extracellular matrix is modifiable by the cellular component in accordance with the external load. Detailed imaging and metabolic studies spurred by the development of the confocal microscope and PCR-based diagnostics have revealed that many disease conditions that were previously thought of as being chronic inflammatory in nature are actually indolent bacterial biofilm infections. These include osteomyelitis associated with S. aureus and Staphylococcus

epidermidis (Marrie & Costerton 1985; Costerton, 2005); gall bladder disease (Sung et al., 1991; Stewart et al., 2007); various chronic middle-ear disease processes associated with H. influenzae, S. pneumoniae, Pritelivir cost Moraxella catarrhalis, and Pseudomonas aeruginosa including otitis media with effusion, recurrent otitis media, and otorrhea (Rayner et al., 1998; Ehrlich et al., 2002; Post et al., 2004; Dohar et al., 2005; Hall-Stoodley et al., 2006; Bakaletz, 2007; Kerschner et al., 2007; Post & Ehrlich, 2007, 2009; Apicella, 2009); chronic rhinosinusitis associated with H. influenzae, S. aureus, and other bacteria (Palmer, 2006; Sanderson (-)-p-Bromotetramisole Oxalate et al., 2006; Psaltis et al., 2007; Prince et al.,

2008); cholesteatoma associated with P. aeruginosa (Chole & Faddis, 2002); tonsillitis (Chole & Faddis, 2003); and adenoiditis associated with H. influenzae, S. pneumoniae, and M. catarrhalis (Zuliani et al., 2006; Nistico et al., 2009). In addition, there is substantial evidence to support a bacterial biofilm etiology for many chronic infections of the urogenital systems of both men and women including cystitis, prostatitis, vaginitis, and endometritis (Nickel et al., 1994; Hua et al., 2005; Swidsinski et al., 2008), and recently, both S. aureus and S. epidermidis have been demonstrated to form biofilms at surgical site infections (Kathju et al., 2009). Biofilms are also associated with dental infections including plaque, endodontitis (Carr et al.

Strips were rinsed briefly with 25% 1.5 M pH 8.0 Tris before SDS–PAGE was performed using Criterion 12.5% Tris-HCl Precast gels (Bio-Rad), run at 200 V for approximately 45 min. For each sample, two gels were run simultaneously, one for silver staining and another for

immunoblotting. Gels for silver staining were fixed individually in 0.1 L fixing solution [50% (v/v) methanol, 10% (v/v) acetic acid] for learn more a minimum of 1 h, and were subsequently stained using a sensitive ammoniacal silver method based on silver nitrate. Gel images were acquired using the UMAX Powerlook 1000 flat-bed scanner. Proteins from unstained gels were transferred electrophoretically onto polyvinylidene fluoride (PVDF) membranes using the Trans-blot cell transfer system (Bio-Rad Laboratories). GPCR Compound Library clinical trial To visualize total proteins, membranes were stained with a Sypro Ruby blot stain (Bio-Rad

Laboratories). To detect immunoreactive proteins, membranes were destained and subsequently probed according to the Immun-Star™ WesternC™ kit protocol (Bio-Rad Laboratories). Membranes were immunolabeled with patients’ sera at a 1 : 250 dilution, and goat anti-human IgG antibodies coupled to HRP (1 : 2000; Bio-Rad) were used as a secondary antibody. The immunoreactive protein spots matched using both the Sypro Ruby stained membrane and the silver-stained gels were identified by liquid chromatography–tandem mass spectrometry (LC–MS/MS). Briefly, spots were washed twice for 10 min in 200 μL of 100 mM NH4HCO3, reduced at 37 °C for 1 h with 50 μL of 10 mM DTT, alkylated for 1 h in 50 μL of 10 mM iodoacetamide, washed for 10 min with 200 μL of 10 mM NH4HCO3, dehydrated in acetonitrile, and trypsin-digested with 10 ng μL−1 of trypsin (Promega, Annandale, NSW, Australia). After digestion for 14 h at 37 °C, peptides were extracted by washing the gel slice for 15 min with 25 μL 1% formic acid, followed by dehydration in acetonitrile. Digests were then dried in vacuo, resuspended in 10 μL 1% formic acid and submitted for

a Quadrupole-TOF analysis on a Micromass instrument which generated collision-induced dissociation. Results were analyzed using the Mascot MS/MS ion search (Matrix Science, Boston, MA), and searches were performed on the National Centre for Biotechnology selleck screening library Information non-redundant (NCBI nr) database (specifically against the available genome sequence of C. concisus BAA-1457). This study was approved by the Research Ethics Committees of the University of New South Wales and the South East Sydney Area Health Service-Eastern Section, Sydney (Ethics No.: 03/163, 03/165 and 06/164). Recently, an association between the presence of C. concisus DNA and newly diagnosed CD was reported in two case–control studies using intestinal biopsies and fecal samples (Zhang et al., 2009; Man et al., 2010c). In addition, significantly higher levels of C. concisus-specific IgG antibodies were detected in children with CD as compared with controls (Zhang et al.

Antifungal–drug interactions that involve CYP-mediated biotransformation of other medications are summarised in Table 1. For a more detailed discussion of drug interactions between mould-active azoles and medicines in general, the reader is referred to more comprehensive reviews.60,61 Interactions involving azoles and benzodiazepines/anxiolytics.  All the azoles including posaconazole significantly inhibit CYP3A metabolism of i.v. or oral midazolam.62–65 Itraconazole and fluconazole also significantly inhibit the CYP3A4 metabolism of triazolam.66–69 Voriconazole and posaconazole likely interact with triazolam, but there have been no published data to date to confirm such an interaction. Midazolam and triazolam

are subjected to significant presystemic (‘first-pass’) metabolism, and

thus the interaction between Birinapant these benzodiazepines and the azoles likely results from inhibition of intestinal and hepatic CYP3A4.4 The interaction between the azoles and the benzodiazepines is typically long-lasting, particularly if both drugs are administered orally.62,64,66,69,70 For example, when administered with itraconazole, the interactions persist for up to 4 days after check details discontinuing the azole.63,67 The itraconazole metabolites likely play a role in the persistence of the interaction.27 Itraconazole metabolites are potent CYP3A4 inhibitors in vitro and the N-desalkyl-itraconazole metabolite has a much longer half-life than the other metabolites or the parent compound.25,27 Moreover, this particular

metabolite substantially contributes to CYP3A4 inhibition for at least 24 h or perhaps more.27 The interactions augment the pharmacodynamic effects of the benzodiazepines including deep and prolonged hypnotic and sedative effects, prolonged GBA3 amnesia and reduced psychomotor performance.62,66,70 Unlike midazolam and triazolam, diazepam undergoes little first-pass metabolism, and it is also metabolised by CYP2C19.71 Itraconazole, fluconazole and voriconazole all significantly increase the systemic exposure of diazepam, but the interactions produce little or only moderate changes in the pharmacodynamic effects of this benzodiazepine.71,72 To date there are no published data describing the potential of diazepam to interact with posaconazole. Benzodiazepines that are unaffected by concomitant administration of an azole, e.g. itraconazole, include temazepam, bromazepam and estolam.73–75 Depending on the case, these agents could be considered as alternative benzodiazipines to use. The non-benzodiazepine anxiolytic buspirone should be used cautiously with the azoles. While there are no data for fluconazole, voriconazole or posaconazole, the interaction with itraconazole results in moderate psychomotor deficits.76 Interactions involving azoles and immunosuppressants.  The azoles interact with commonly used immunosuppressive agents (i.e. calcineurin inhibitors, corticosteroids, sirolimus).

The function of NK cells was also improved as shown by an increase in IFN-γ secretion and cytotoxic activity against an HPV+ cell line. This crosstalk between NK cells and DCs needed CD40 interaction and IL-12p70 secretion, whereas NKG2D was not implicated. Our results provide insight into how VLPs interact with innate immune cells and how NK cells and DCs play a role in the immune response induced by this vaccine agent. “
“Citation Sharma D, Singh A, Trivedi SS, Bhattacharjee J. Role of endothelin and inflammatory cytokines in pre-eclampsia – a pilot north Indian study. Am J Reprod Immunol 2011; 65: 428–432 Problem  Pre-eclampsia is new onset hypertension

during pregnancy with proteinuria. The initiating event in pre-eclampsia is postulated to involve reduced Selumetinib nmr placental perfusion, which leads

to widespread dysfunction of the maternal vascular endothelium. Cytokines also appear to contribute to the development of the pathological condition. The aim of this study was to evaluate the role of cytokines in pre-eclampsia and to study the relationship between endothelin-1 and cytokines with the severity of the disease. Method of study  This cross-sectional study included 300 women with pre-eclampsia and 200 healthy pregnant women. Their blood samples were analyzed for endothelin-1 and inflammatory cytokines. Results  Increased endothelin-1 and cytokines [tumor necrosis factor-α, interleukin-2 (IL-2) and γ-interferon (IFN-γ)] levels were found in pre-eclampsia (P < 0.001). Significant positive correlation was seen between endothelin-1 and cytokine level (IL-2 KPT-330 cost and IFNγ) in the pre-eclamptic group (P = 0.001). Conclusion  We conclude that pre-eclampsia is associated with increased levels of both endothelin-1 and circulating inflammatory cytokines, which points toward the role of endothelial and inflammatory components. “
“Research on infectious diseases DNA ligase using animal models has been a successful example of translational research. However, because chronic infections are

still one of the main causes of death and disability in the world, it is expected that a great number of mice will continue to be used to address this subject. Although increasing awareness regarding animal welfare has led to novel recommendations for animal housing enrichment, studies evaluating the impact of these modifications on the immune response to infection are lacking. The present study shows that validated and recommended simple environmental enrichment does not interfere with the immune response to chronic infection with Mycobacterium avium for up to 20 weeks, as assessed by the bacterial load in the spleen and lung, by the number and activation status of the main cell populations of the immune system and the serum concentration of interferon-gamma. Therefore, enrichment can be encouraged without concern regarding comparability of results among laboratories studying this type of chronic infections.